NGS vs PGS Which Is More Lucrative?

Next-generation sequencing (NGS) and preimplantation genetic screening (PGS) are two popular techniques used in the field of genetics and biotechnology. NGS involves the high-throughput sequencing of DNA to uncover genetic variations, while PGS is utilized in the screening of embryos for genetic abnormalities before implantation. Both techniques have revolutionized genetic testing and diagnosis, leading to the emergence of lucrative stocks in the biotech industry. Investors are often torn between NGS and PGS stocks, as both offer promising opportunities for growth and innovation in the rapidly developing field of genetics.

NGS or PGS?

When comparing NGS and PGS, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between NGS and PGS.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. NGS has a dividend yield of -%, while PGS has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. NGS reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, PGS reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with NGS P/E ratio at -0.15 and PGS's P/E ratio at 18.51. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. NGS P/B ratio is 0.29 while PGS's P/B ratio is 1.49.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, NGS has seen a 5-year revenue growth of -0.20%, while PGS's is -0.70%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with NGS's ROE at -170.33% and PGS's ROE at 8.60%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are kr3.08 for NGS and kr8.88 for PGS. Over the past year, NGS's prices ranged from kr2.86 to kr7.48, with a yearly change of 161.54%. PGS's prices fluctuated between kr6.06 and kr10.45, with a yearly change of 72.30%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.